Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients

Human Immunology

Volumn 73, Issue 9, 2012, Pages 950-953

  Skarmoutsou, Evangelia ^a   D'Amico, Fabio ^a   Marchini, Maurizio ^b   Malaponte, Grazia ^a   Scorza, Raffaella ^b   Mazzarino, Maria Clorinda ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FINGER ULCER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS;

AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCLERODERMA, SYSTEMIC; SEX FACTORS; SKIN ULCER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84865363219     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.07.040     Document Type: Article

References (30)

1. Silver R.M. Clinical aspect of systemic sclerosis (scleroderma). Ann Rheum Dis 1991, 50:854-861.
2. Agarwal S.K., Tan F.K., Arnett F.C. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 2008, 34:17-40.
3. Rodnan G., Myerowitz R., Justh G. Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine 1980, 59:393-408.
4. Fleming J.N., Nash R.A., Mahoney W.M., Schwartz S.M. Is scleroderma a vasculopathy?. Curr Rheumatol Rep 2009, 11:103-110.
5. Eming S.A., Hubbell J.A. Extracellular matrix in angiogenesis: dynamic structures with translational potential. Exp Dermatol 2011, 20:605-613.
6. Distler J.H., Gay S., Distler O. Angiogenesis and vasculogenesis in systemic sclerosis. Rheumatology (Oxford) 2006, (Suppl. 3):iii26-iii27.
7. Manetti M., Liakouli V., Fatini C., Cipriani P., Bonino C., Vettori S., et al. Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis. Ann Rheum Dis 2009, 68:408-411.
8. Wipff J., Bonnet P., Ruiz B., Dieude P., Avouac J., Tiev K., et al. Association study of serotonin transporter gene (SLC6A4) in systemic sclerosis in European Caucasian populations. J Rheumatol 2010, 37:1164-1167.
9. Zhou X., Tan F.K., Xiong M., Arnett F.C., Feghali-Bostwick C.A. Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles. Arthritis Rheum 2005, 52:3305-3313.
10. Varga J., Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007, 117:557-567.
11. Hoshino K., Satoh T., Kawaguchi Y., Kuwana M. Association of hepatocyte growth factor promoter polymorphism with severity of interstitial lung disease in Japanese patients with systemic sclerosis. Arthritis Rheum 2011, 63:2465-2472.
12. Agarwal S.K. The genetics of systemic sclerosis. Discov Med 2010, 10:134-143.
13. Rifkin D.B., Gross J.L., Moscatelli D., Gabrielides C. The involvement of proteases and protease inhibitors in neovascularization. Acta Biol Med Ger 1981, 40:1259-1263.
14. Susol E., Rands A.L., Herrick A., McHugh N., Barrett J.H., Ollier W.E., et al. Association of markers for TGFbeta3, TGFbeta2 and TIMP1 with systemic sclerosis. Rheumatology (Oxford) 2000, 39:1332-1336.
15. Indelicato M., Chiarenza V., Libra M., Malaponte G., Bevelacqua V., Marchini M., et al. Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients. J Clin Lab Anal 2006, 20:173-176.
16. Meijer M.J., Mieremet-Ooms M.A., van Hogezand R.A., Lamers C.B., Hommes D.W., Verspaget H.W. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J Gastroenterol 2007, 13:2960-2966.
17. Burkhardt J., Petit-Teixeira E., Teixeira V.H., Kirsten H., Garnier S., Ruehle S., et al. Association of the X-chromosomal genes TIMP1 and IL9R with rheumatoid arthritis. J Rheumatol 2009, 36:2149-2157.
18. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-590. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.
19. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A. Scleroderma (systemic sclerosis): classification, subset and pathogenesis. J Rheumatol 1988, 15:202-205.
20. Dupont W.D., Plummer W.D. Power and sample size calculations for studies involving linear regression. Controlled Clin Trials 1998, 19:589-601.
21. Kirk T.Z., Mark M.E., Chua C.C., Chua B.H., Mayes M.D. Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 1995, 270:3423-3428.
22. Mattila L., Airola K., Ahonen M., Hietarinta M., Black C., Saarialho-Kere U., et al. Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol 1998, 110:416-421.
23. Young-Min S.A., Beeton C., Laughton R., Plumpton T., Bartram S., Murphy G., et al. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls. Ann Rheum Dis 2001, 60:846-851.
24. Kikuchi K., Kubo M., Sato S., Fujimoto M., Tamaki K. Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis. J Am Acad Dermatol 1995, 33:973-978.
25. Anderson Cl, Brown C.J. Polymorphic X-chromosome inactivation of the human TIMP1 gene. Am J Hum Genet 1999, 65:699-708.
26. Ozbalkan Z., Bagislar S., Kiraz S., Akyerli C.B., Ozer H.T., Yavuz S., et al. Skewed X-chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 2005, 52:1564-1570.
27. Broen J.C., Wolvers-Tettero I.L., Geurts-van Bon L., Vonk M.C., Coenen M.J., Lafyatis R., et al. Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis. Ann Rheum Dis 2010, 69:2213-2216.
28. Sebastiani M., Manfredi A., Vukatana G., Moscatelli S., Riato L., Bocci M., et al. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis 2012, 71:67-70.
29. Rossi P., Granel B., Marziale D., Le Mée F., Francès Y. Endothelial function and hemodynamics in systemic sclerosis. Clin Physiol Funct Imaging 2010, 30:453-459.
30. Allanore Y., Borderie D., Meune C., Lemaréchal H., Weber S., Ekindjian O.G., et al. Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers. Ann Rheum Dis 2005, 64:481-483.